SII has also been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events
Phase 2 trials: Vital signs of volunteers in Pune administered with Oxford COVID-19 vaccine normal, say doctors
Serum Institute of India has signed an agreement to manufacture a potential COVID-19 vaccine developed by Oxford University in collaboration with AstraZeneca
Phase II human trial of Oxford's COVID-19 vaccine begins at Pune hospital; 32-year-old administered the first shot
Doctors administered the first shot of 'Covishield' after tests related to COVID-19 and antibodies came negative, officials said
COVID-19 vaccine: Serum Institute of India to begin Phase 2 trial of Oxford-Astrazeneca candidate today
The DCGI on 3 August had given nod to the Pune Serum Institute of India for conducting phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate
Oxford COVID-19 vaccine: Panel recommends that DCGI grant Serum Institute permission for human trials
The DCGI had earlier asked SII to clearly define Phase 2 and Phase 3 of trials and resubmit their application for evaluation.
WHO has said multiple vaccine approaches are necessary for COVID-19, considering success rates for vaccine development are around 10%.